Sofinnova Management X-a, L.l.c. - Net Worth and Insider Trading

Sofinnova Management X-a, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sofinnova Management X-a, L.l.c. owns 2 companies in total, including Vera Therapeutics Inc (VERA) , and CinCor Pharma Inc (CINC) .

Click here to see the complete history of Sofinnova Management X-a, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Sofinnova Management X-a, L.l.c.

Ticker	Comapny	Transaction Date	Type of Owner
VERA	Vera Therapeutics Inc	2023-02-06	10 percent owner
CINC	CinCor Pharma Inc	2022-11-28	10 percent owner

Sofinnova Management X-a, L.l.c. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sofinnova Management X-a, L.l.c. Ownership Network

Ownership Network List of Sofinnova Management X-a, L.l.c.

No Data

Ownership Network Relation of Sofinnova Management X-a, L.l.c.

Sofinnova Management X-a, L.l.c. Owned Company Details

What does Vera Therapeutics Inc do?

Who are the key executives at Vera Therapeutics Inc?

Sofinnova Management X-a, L.l.c. is the 10 percent owner of Vera Therapeutics Inc. Other key executives at Vera Therapeutics Inc include SVP & Finance & Chief Acct Offcr Joseph R Young , Chief Financial Officer Sean Grant , and director & 10 percent owner Maha Katabi .

Vera Therapeutics Inc (VERA) Insider Trades Summary

Over the past 18 months, Sofinnova Management X-a, L.l.c. made no insider transaction in Vera Therapeutics Inc (VERA). Other recent insider transactions involving Vera Therapeutics Inc (VERA) include a net purchase of 441,721 shares made by Beth C Seidenberg , a net sale of 23,907 shares made by Joanne Curley , and a net sale of 99,192 shares made by Sean Grant .

In summary, during the past 3 months, insiders sold 958,650 shares of Vera Therapeutics Inc (VERA) in total and bought 0 shares, with a net sale of 958,650 shares. During the past 18 months, 2,039,257 shares of Vera Therapeutics Inc (VERA) were sold and 4,784,797 shares were bought by its insiders, resulting in a net purchase of 2,745,540 shares.

Vera Therapeutics Inc (VERA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vera Therapeutics Inc Insider Transactions

No Available Data

Sofinnova Management X-a, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Sofinnova Management X-a, L.l.c.. You might contact Sofinnova Management X-a, L.l.c. via mailing address: 3000 Sand Hill Road, 4-250, Menlo Park Ca 94025.

Discussions on Sofinnova Management X-a, L.l.c.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.